LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-27,66 % | 9,41 Mrd. | |
+26,94 % | 2,9 Mrd. | |
-15,73 % | 2,16 Mrd. | |
-20,83 % | 1,7 Mrd. | |
+67,18 % | 1,51 Mrd. | |
+26,08 % | 814 Mio. | |
-4,15 % | 760 Mio. | |
-28,78 % | 529 Mio. | |
+3,98 % | 312 Mio. |